Cathepsin cysteine protease inhibitors
US7279478B2 · kind B2 · utility
8Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2003 |
| Grant date | Oct 9, 2007 |
| Priority date | — |
| Expiry date | May 8, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis. They have the following structure: Formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.